OVARIAN SERTOLI-LEYDIG CELL TUMOUR

This adverse event was reported 8 times

These drugs are most commonly taken by patients reporting OVARIAN SERTOLI-LEYDIG CELL TUMOUR:

# Drug Count
0 CYCLOPHOSPHAMIDE 4
1 CYCLOPHOSPHAMIDE FOR INJECTION 4
2 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 4
3 DACTINOMYCIN 2
4 ADALIMUMAB 1
5 BEVACIZUMAB 1
6 BUSULFAN 1
7 CELECOXIB 1
8 CISPLATIN 1
9 CYCLOSPORINE 1
See all common drugs associated with OVARIAN SERTOLI-LEYDIG CELL TUMOUR

OVARIAN SERTOLI-LEYDIG CELL TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DACTINOMYCIN 2 0.0009
1 TALAZOPARIB 1 0.0005
2 BUSULFAN 1 0.0001
3 CYCLOPHOSPHAMIDE FOR INJECTION 4 0.0000
4 CYCLOPHOSPHAMIDE 4 0.0000
5 CISPLATIN 1 0.0000
6 CYCLOSPORINE 1 0.0000
7 BEVACIZUMAB 1 0.0000
8 TACROLIMUS OINTMENT 0.1% 1 0.0000
9 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
See all drugs enriched for association with OVARIAN SERTOLI-LEYDIG CELL TUMOUR